Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

172
End-of-day quote. End-of-day quote Swiss Exchange - 07/31
264.7 CHF   -0.75%
1d ago AstraZeneca steps up push into cancer immunotherapy
7d agoDJDrug Companies Oppose Moves to Reimburse Off-Label Medicine
07/24 ROCHE : breast cancer drugs keep it on track to meet targets
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
07/25/2014 07/28/2014 07/29/2014 07/30/2014 07/31/2014 Date
267(c) 265.5(c) 265.8(c) 266.7(c) 264.7(c) Last
913 262 655 117 1 487 869 906 656 1 201 258 Volume
-0.45% -0.56% +0.11% +0.34% -0.75% Change
More quotes
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
08/06 | 03:15pmPresentation
Surperformance© rating of Roche Holding Ltd.
Trading Rating : Investor Rating :
More about the company
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Financials ( CHF)
Sales 2014 47 167 M
EBIT 2014 17 485 M
Net income 2014 12 075 M
Debt 2014 2 963 M
Yield 2014 3,11%
Sales 2015 49 006 M
EBIT 2015 18 561 M
Net income 2015 13 018 M
Finance 2015 1 956 M
Yield 2015 3,34%
PER 2014 18,78
PER 2015 17,19
EV / Sales 2014 4,89x
EV / Sales 2015 4,60x
Capitalization 227 568 M
More Financials
Latest news on ROCHE HOLDING LTD.
1d ago AstraZeneca steps up push into cancer immunotherapy
7d agoDJDrug Companies Oppose Moves to Reimburse Off-Label Medicine
07/24 ROCHE : breast cancer drugs keep it on track to meet targets
07/24DJROCHE : Profit Dented by Currencies
07/22DJRoche Holding AG 1st Half 2014 -- Forecast
07/22 ROCHE : FDA Grants Genentech’s Avastin Priority Review for Recurrent Plati..
07/19DJRoche Not Interested in Large Acquisitions, Says CEO -- Report
07/19 Roche CEO plans to steer clear of big acquisitions
07/15 ROCHE : FDA Grants Genentech’s Avastin Priority Review for Certain Types o..
07/14 ROCHE : Genentech :’s Investigational Medicine Cobimetinib, Used in Combin..
07/02DJEUROPE MARKETS : Alcatel Higher In Europe, But Orange Shares Sour
07/02DJEUROPE MARKETS : Alcatel, Roche Up In Europe, But Orange Shares Sour
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Roche Holding Ltd. : Income Statement Evolution
More Financials
EPS Revisions
Roche Holding Ltd. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF